Insider Stock Trading History of Shah Gautam


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Shah Gautam since year 2005. The trader's CIK number is 1378586. At the time of this reporting, Shah Gautam is the SVP and Chief Compli of Achillion Pharmaceuticals Inc . (stock ticker symbol ACHN). See this page for all insider trading activities at Achillion Pharmaceuticals Inc .


Stock purchases, sales, and option exercises reported by insider Shah Gautam since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2013-01-02 ACHN Achillion Pharmaceuticals Inc Sale 26,965 8.40 226,613
2012-12-31 ACHN Achillion Pharmaceuticals Inc Option Ex 88,168 2.08 182,948
2012-12-31 ACHN Achillion Pharmaceuticals Inc Sale 88,168 8.01 706,049
2013-01-02 ACHN Achillion Pharmaceuticals Inc Option Ex 26,965 3.19 86,018
2012-09-27 ACHN Achillion Pharmaceuticals Inc Sale 7,005 10.00 70,050
2012-09-27 ACHN Achillion Pharmaceuticals Inc Option Ex 7,005 4.82 33,764
2012-09-12 ACHN Achillion Pharmaceuticals Inc Option Ex 11,250 2.40 27,000
2012-09-12 ACHN Achillion Pharmaceuticals Inc Sale 11,250 8.00 90,000
2012-03-19 ACHN Achillion Pharmaceuticals Inc Sale 2,078 10.52 21,860
2012-03-19 ACHN Achillion Pharmaceuticals Inc Option Ex 2,078 3.28 6,815
2012-03-16 ACHN Achillion Pharmaceuticals Inc Sale 2,718 10.87 29,544
2012-03-16 ACHN Achillion Pharmaceuticals Inc Option Ex 2,718 1.05 2,853
2012-01-10 ACHN Achillion Pharmaceuticals Inc Sale 25,745 11.35 292,282
2012-01-10 ACHN Achillion Pharmaceuticals Inc Option Ex 25,745 3.29 84,701
2011-12-20 ACHN Achillion Pharmaceuticals Inc Sale 5,625 8.00 45,000
2011-12-19 ACHN Achillion Pharmaceuticals Inc Sale 2,079 7.51 15,613
2011-12-20 ACHN Achillion Pharmaceuticals Inc Option Ex 5,625 4.82 27,112
2011-12-19 ACHN Achillion Pharmaceuticals Inc Option Ex 2,079 3.28 6,819
2011-12-16 ACHN Achillion Pharmaceuticals Inc Sale 2,719 7.18 19,522
2011-12-16 ACHN Achillion Pharmaceuticals Inc Option Ex 2,719 1.05 2,854
2011-12-01 ACHN Achillion Pharmaceuticals Inc Option Ex 2,078 3.28 6,815
2011-12-01 ACHN Achillion Pharmaceuticals Inc Sale 2,078 7.00 14,546
2011-09-16 ACHN Achillion Pharmaceuticals Inc Sale 2,719 5.90 16,042
2011-09-16 ACHN Achillion Pharmaceuticals Inc Option Ex 2,719 1.05 2,854
2011-06-28 ACHN Achillion Pharmaceuticals Inc Option Ex 19,625 4.41 86,546
2011-06-28 ACHN Achillion Pharmaceuticals Inc Sale 19,625 8.00 157,000
2011-06-22 ACHN Achillion Pharmaceuticals Inc Option Ex 2,078 1.05 2,181
2011-06-22 ACHN Achillion Pharmaceuticals Inc Sale 2,078 7.00 14,546
2011-06-16 ACHN Achillion Pharmaceuticals Inc Sale 2,719 6.44 17,510
2011-06-16 ACHN Achillion Pharmaceuticals Inc Option Ex 2,719 1.05 2,854
2011-04-15 ACHN Achillion Pharmaceuticals Inc Option Ex 11,000 2.16 23,760
2011-04-15 ACHN Achillion Pharmaceuticals Inc Sale 11,000 6.60 72,644
2011-03-16 ACHN Achillion Pharmaceuticals Inc Sale 2,726 6.11 16,655
2011-03-15 ACHN Achillion Pharmaceuticals Inc Sale 5,000 5.94 29,725
2011-03-16 ACHN Achillion Pharmaceuticals Inc Option Ex 2,726 1.05 2,862
2011-03-15 ACHN Achillion Pharmaceuticals Inc Option Ex 5,000 1.05 5,250
2011-01-18 ACHN Achillion Pharmaceuticals Inc Sale 14,312 4.86 69,527
2011-01-18 ACHN Achillion Pharmaceuticals Inc Option Ex 14,312 1.88 26,935
2007-04-26 ACHN Achillion Pharmaceuticals Inc Sale 1,025 5.73 5,875
2007-04-25 ACHN Achillion Pharmaceuticals Inc Option Ex 2,100 1.60 3,360
2007-04-26 ACHN Achillion Pharmaceuticals Inc Option Ex 1,025 1.60 1,640
2007-04-25 ACHN Achillion Pharmaceuticals Inc Sale 2,100 5.85 12,278
2006-12-04 ACHN Achillion Pharmaceuticals Inc Option Ex 3,125 1.60 5,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Shah Gautam (SVP and Chief Compli of Achillion Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.